By examining the IGFBP-3 A-202C polymorphism in the context of both IGFBP-3 and IGF-1 serum levels, we clarify the role of this polymorphism as a biomarker for early breast cancer detection, particularly in Palestinian women. Here, IGF1 is linked to breast carcinoma.